Bausch + Lomb Corporation
Bausch + Lomb Corporation (BLCO.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BLCO.TO · as of Jun 8, 2026
Key Statistics
Explore Bausch + Lomb Corporation Data
blco.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 35.7%
Competitors & Peers
blco.to competitorsBLCO.TO
BHC.TO
CURA.TO
EDT.TO
FRX.TO
OTC.VStock Performance
Full HistoryAbout Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/C…
what is bausch + lomb corporation · blco.to stock overview · bausch + lomb corporation company profile · who is bausch + lomb corporation ceo · blco.to TSX · bausch + lomb corporation headquarters · bausch + lomb corporation business segments
About Stock Overview & Key Data
Bausch + Lomb Corporation (BLCO.TO) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on TSX since May 6, 2022. As of the latest trading session, BLCO.TO stock price is $21.64, with a market capitalization of $7.7B. The stock has returned +32.27% over the past 12 months and -7.72% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Bausch + Lomb Corporation stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Bausch + Lomb Corporation reported revenue of $5.1B and net income of -$360.0M. For detailed data — including Bausch + Lomb Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bausch + Lomb Corporation (BLCO.TO) stock price is $21.64. The stock is traded on TSX under the ticker symbol BLCO.TO. The 52-week range is $15.69 – $25.70.